Adult growth hormone deficiency: to treat or not to treat

Bibliography

• GHARIB H, COOK DM, SAENGER PH, BENGTSSON BA et al., AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS GROWTH HORMONE TASK FORCE 2003: American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children--2003 update. Endocr. Pract. (2003) 9:64-76.
   PubMedGoogle Scholar
• ROSEN T, BENGTSSON BA: Premature mortality due to cardiovascular disease in hypopituitarism. Lancet (1990) 336:285-288.
   PubMed Web of Science ®Google Scholar
• GOTH MI, HUBINA E, CARBONITS M: Aetiology and demography of adult growth hormone deficiency In: Growth Hormone deficiency in adults: 10 years of KIMS. Abs R, Feldt-Rasmussen U (Eds), Oxford PharmaGenesis Ltd, Oxford (2004):75-83.
   Google Scholar
• MOLITCH ME, CLEMMONS DR, MALOZOWSKI S et al.: Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. (2006) 91:1621-1634.
   PubMed Web of Science ®Google Scholar
• HOFFMAN DM, O’SULLIVAN AJ, BAXTER RC, HO KY: Diagnosis of growth hormone deficiency in adults. Lancet (1994) 343:1064-1068
   PubMed Web of Science ®Google Scholar
• SVENSSON J, JOHANNSSON G, BENGTSSON BA: Insulin-like growth factor-I in growth hormone-deficient adults: relationship to population-based normal values, body composition and insulin tolerance test. Clin. Endocrinol. (Oxf) (1997) 46:579-586
   PubMed Web of Science ®Google Scholar
• TOOGOOD AA, BEARDWELL CG, SHALET SM. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin. Endocrinol. (Oxf.) (1994) 41:511-516.
   PubMed Web of Science ®Google Scholar
• HARTMAN ML, CROWE BJ, BILLER BM, HO KK, CLEMMONS DR, CHIPMAN JJ: Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J. Clin. Endocrinol. Metab. (2002) 87:477-485.
   PubMed Web of Science ®Google Scholar
• AIMARETTI G, CORNELI G, RAZZORE P et al.: Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone L-arginine as provocative tests for the diagnosis of GH deficiency in adults. J. Clin. Endocrinol. Metab. (1998) 83:1615-1618
   PubMed Web of Science ®Google Scholar
• HOECK HC, VESTERGAARD P, JAKOBSEN PE, FALHOF J, LAURBERG P: Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycaemia as GH secretagogues. J. Clin. Endocrinol. Metab. (2000) 85:1467-1472.
   PubMed Web of Science ®Google Scholar
• BILLER BMK, SAMUELS MH, ZAGAR A et al.: Sensitivity and specificity of six tests for the diagnosis of adult GH J. Clin. Endocrinol. Metab. (2002) 87:2067-2079.
   PubMed Web of Science ®Google Scholar
• LITTLEY MD, SHALET SM, BEARDWELL CG, AHMED SR, APPLEGATE G, SUTTON ML: Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med. (1989) 70:145-160.
   PubMedGoogle Scholar
• CASANUEVA FF, GHIGO E, POPOVIC V, ATHENS TBI, HYPOPITUITARISM STUDY GROUP: Hypopituitarism following traumatic brain injury (TBI): a guideline decalogue. J. Endocrinol. Invest. (2004) 27:793-795.
   PubMed Web of Science ®Google Scholar
• AIMARETTI G, AMBROSIO MR, DI SOMMA C et al.: Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin. Endocrinol. (2004) 61:320-326.
   PubMed Web of Science ®Google Scholar
• AGHA A, ROGERS B, SHERLOCK M et al.: Anterior pituitary dysfunction in survivors of traumatic brain injury. J. Clin. Endocrinol. Metab. (2004) 89:4929-4936.
   PubMed Web of Science ®Google Scholar
• TZANELA M, KARAVITAKI N, STYLIANIDOU C, TSAGARAKIS S, THALASSINOS NC: Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome. Clin. Endocrinol. (2004) 60:309-314.
   PubMed Web of Science ®Google Scholar
• CHRISTOPHORAKI M, PAPASTATHOPOULOU L, AMIRIDOU CH, TZANELA M, THALASSINOS N: Recovery of GH secretion after medical treatment of macroprolactinomas. 11th European Neuroendocrine Association Meeting. Naples, Italy (2004)
   Google Scholar
• BONERT VS, ELASHOFF JD, BARNETT P, MELMED S: Body mass index determines evoked growth hormone (GH) responsiveness in normal healthy male subjects: diagnostic caveat for adult GH deficiency. J. Clin. Endocrinol. Metab. (2004) 89:3397-3401.
   PubMed Web of Science ®Google Scholar
• ZIANNI D, BILARIKI K, GAVALAS N, BOTOULA E, TZANELA M, THALASSINOS N: Influence of body mass index on GH responsiveness in normal heathy subjects and patients with pituitary adenoma. 7th Meeting of the European Society of Endocrinology. Gutenborg, Sweden (2005)
   Google Scholar
• CORNELI G, DI SOMMA C, BALDELLI R et al.: The cutoff limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur. J. Endocrinol. (2005) 153:257-264.
   PubMed Web of Science ®Google Scholar
• SPAN JP, PIETERS GFF SWEEP CG, HERMUS AR, SMALS AG: Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement. J. Clin. Endocrinol. Metab. (2000) 85:1121-1125.
   PubMed Web of Science ®Google Scholar
• COOK DM, LUDLAM WH, COOK M et al.: Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults J. Clin. Endocrinol. Metab. (1999) 84:3956-3960.
   PubMed Web of Science ®Google Scholar
• GIAVOLI C, PORRETTI S, FERRANTE E et al.: Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism? Clin. Endocrinol. (Oxf.) (2003) 59:806-810.
   PubMed Web of Science ®Google Scholar
• GIAVOLI C, LIBE R, CORBETTA S et al.: Effect of recombinant human growth hormone (GH) replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients J. Clin. Endocrinol. Metab. (2004) 89:5397-5401.
   PubMed Web of Science ®Google Scholar
• SVENSSON J, MATTSSON A, ROSEN T et al.: Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption. Growth Horm. IGF Res. (2004) 14:207-215.
   PubMed Web of Science ®Google Scholar
• MONSON JP, BENGTSSON BA, ABS R, FELDT-RASMUSSEN U, WUSTER C: An growth hormone therapy cause diabetes? KIMS Strategic Committee. Lancet (2000) 355:1728-1729.
   PubMed Web of Science ®Google Scholar
• SVENSSON J, BENGTSSON BA, ROSEN T, ODEN A, JOHANNSSON G: Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. J. Clin. Endocrinol. Metab. (2004) 89:3306-3312.
   PubMed Web of Science ®Google Scholar
• BATES AS, VAN’T HOFF W, JONES PJ, CLAYTON RN: The effect of hypopituitarism on life expectancy. J. Clin. Endocrinol. Metab. (1996) 81:1169-1172.
   PubMed Web of Science ®Google Scholar
• BULOW B, HAGMAR L, MIKOCZY Z, NORDSTROM CH, ERFURTH EM: Increased cerebrovascular mortality in patients with hypopituitarism. Clin. Endocrinol. (Oxf) (1997) 46:75-81.
   PubMed Web of Science ®Google Scholar
• BATES AS, BULLIVANT B, SHEPPARD MC, STEWART PM: Life expectancy following surgery for pituitary tumours. Clin. Endocrinol. (Oxf) (1999) 50:315-319.
   PubMed Web of Science ®Google Scholar
• TOMLINSON JW, HOLDEN N, HILLS RK, WHEATLEY K, CLAYTON RN, BATES AS: Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet (2001) 357:425-431.
   PubMed Web of Science ®Google Scholar
• BESSON A, SALEMI S, GALLATI S, JENAL A, HORN R, MULLIS PS, MULLIS PE: Reduced longevity in untreated patients with isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. (2003) 88:3664-3667.
   PubMed Web of Science ®Google Scholar
• BENGTSSON BA, EDEN S, LONN L, KVIST H, STOKLAND A, LINDSTEDT G: Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J. Clin. Endocrinol. Metab. (1993) 76:309-317.
   PubMed Web of Science ®Google Scholar
• KARELIS A, ST PIERRE DH, CONUS F, RABASA-LHORET R, POEHLMAN ET et al.: Metabolic and body composition factors in subgroups of obesity: What do we know? J. Clin. Endocrinol. Metab. (2004) 89:2569-2575.
   PubMed Web of Science ®Google Scholar
• CHRISOULIDOU A, KOUSTA E, BESHYAH SA, ROBINSON S, JOHNSTON DG: How much, and by what mechanisms, does growth hormone replacement improve the quality of life in GH-deficient adults? Baillieres Clin. Endocrinol. Metab.(1998) 12:261-279.
   PubMed Web of Science ®Google Scholar
• GIBNEY J, WALLACE JD, SPINKS T et al.: The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients.J. Clin. Endocrinol. Metab. (1999) 84:2596-2602.
   PubMed Web of Science ®Google Scholar
• GOLA M, BONADONNA S, DOGA M, GUISTINA A: Growth hormone and cardiovascular risk factors J. Clin. Endocrinol. Metab. (2005) 90:1864-1870.
   PubMed Web of Science ®Google Scholar
• MARKUSSIS V, BESHYAH SA, FISHER C, SHARP P, NICOLAIDES AN, JOHNSTON DG: Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet (1992) 340:1188-1192.
   PubMed Web of Science ®Google Scholar
• MARKUSSIS V, BESHYAH SA, FISHER C, PARKER KH, NICOLAIDES AN, JOHNSTON DG: Abnormal carotid arterial wall dynamics in symptom free hypopituitary adults. Eur. J. Endocrinol. (1997) 136:157-164.
   PubMed Web of Science ®Google Scholar
• BOGER RH, SKAMIRA C, BODE-BOGER SM, BRABANT G, VON ZUR MUHLEN A, FROLICH JC: Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. J. Clin. Invest. (1996) 98:2706-2713.
   PubMed Web of Science ®Google Scholar
• BORSON CHAZOT F, SERUSCLAT A, KALFALLAH Y et al.: 1999 decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency. J. Clin. Endocrinol. Metab. (1999) 84:1329-1333.
   PubMed Web of Science ®Google Scholar
• PFEIFER M, VERHOVEC R, ZIZEK B, PREZELJ J, POREDOS P, CLAYTON RN: Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J. Clin. Endocrinol. Metab. (1999) 84:453-457.
   PubMed Web of Science ®Google Scholar
• SESMILO G, BILLER BMK, LLEVADOT J et al.: Effects of growth hormone administration on homocysteine levels in men with GH deficiency: a randomised controlled trial. J. Clin. Endocrinol. Metab. (2001) 86:1518-1524.
   PubMed Web of Science ®Google Scholar
• SESMILO G, BILLER BMK, LLEVADOT J et al.: Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. Ann. Intern. Med. (2000) 133:111-122.
   PubMed Web of Science ®Google Scholar
• RIDKER PM, RIFAI N, PFEFFER MA, SACKS F, BRAUNWALD E: Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1999) 100:230-235.
   PubMed Web of Science ®Google Scholar
• JOHANSSON JO, LANDIN K, TENGBORN L, ROSEN T, BENGSSON BA: High fibrinogen and plasminogen activator inhibitor activity in growth hormone deficient adults. Arterioscler. Thromb. (1994) 14:434-437.
   PubMed Web of Science ®Google Scholar
• COLAO A, DI SOMMA C, PIVONELLO R et al.: The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study. J. Clin. Endocrinol. Metab. (2002) 87:1088-1093.
   PubMed Web of Science ®Google Scholar
• LANES R, PAOLI M, CARRILLO E, VILLAROEL O, PALACIOS A: Cardiovascular risk of young growth-hormone-deficient adolescents. Horm. Res. (2003) 60:291-296.
   PubMedGoogle Scholar
• AMATO G, CARELLA C, FAZIO S et al.: Body composition, bone metabolism and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J. Clin. Endocrinol. Metab. (1993) 77:1671-1676.
   PubMed Web of Science ®Google Scholar
• CUNEO RC, SALOMON F, WATTS GP, HESP R, SONSKEN PH: Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism (1993) 42:1519-1523.
   PubMed Web of Science ®Google Scholar
• MAISON P, GRIFFIN S, NICOUE-BEGLAH M, HADDAD N, BALKAU B: Impact of growth Hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials. J. Clin. Endocrinol. Metab. (2004) 89:2192-2199.
   PubMed Web of Science ®Google Scholar
• OLIVEIRA JLM, MARQUES-SANTOS C, BARRETO-FILHO JA et al.: Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone deficiency due to a GH-releasing hormone receptor mutation, J. Clin. Endocrinol. Metab. (2006) 91:2093-2099.
   PubMed Web of Science ®Google Scholar
• SVENSSON J, FOWELIN J, LANDIN K, BENGTSSON BA: Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. J. Clin. Endocrinol. Metab. (2002) 87:2121-2127.
   PubMed Web of Science ®Google Scholar
• OHLSSON C, BENGTSSON BA, ISAKSSON OG, ANDREASSEN TT, SLOOTWEG MC: Growth hormone and bone. Endocr. Rev. (1998) 19:55-79.
   PubMed Web of Science ®Google Scholar
• COLAO A, DISOMMA C, PIVONELLO R, LOCHE S, AIMARETTI G, CERBONE G: Bone loss is correlated with the severity of growth hormone deficiency in adult patients with hypopituitarism J. Clin. Endocrinol. Metab. (1999) 84:1919-1922.
   PubMed Web of Science ®Google Scholar
• WUSTER C, ABS R, BENGTSSON B-A, BENMARKER H et al.: The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J. Bone Mine. Res. (2001) 16:398-405.
   PubMed Web of Science ®Google Scholar
• MAZZIOTI G, BIANCHI A, BONADONA S et al.: Increased prevalence of radiological spinal deformities in adult patientsa with GH deficiency: influence of GH replacement therapy. J. Bone Miner. Res. (2006) 21:520-528.
   PubMed Web of Science ®Google Scholar
• JOHANNSSON G., ROSEN T, BOSAEUS I, SJOSTROM L, BENGTSSON BA: Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J. Clin. Endocrinol. Metab. (1996) 81:2865-2873.
   PubMed Web of Science ®Google Scholar
• GOTHERSTROM G, SVENSSON J, KORANYI J et al.: Prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. J. Clin. Endocrinol. Metab. (2001) 86:4657-4665.
   PubMed Web of Science ®Google Scholar
• DAVIDSON P, MILNE R, CHASE D, COOPER C: Growth hormone replacement in adults and bone mineral density: a systematic review ant meta-analysis. Clin. Endocrinol. (Oxf) (2004) 60:92-98.
   PubMed Web of Science ®Google Scholar
• CARROL PV, CHRIST ER, BENGTSSON BA et al.: Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review J. Clin. Endocrinol. Metab. (1998) 83:382-395.
   PubMed Web of Science ®Google Scholar
• ATTANASIO AF, LAMBERTS SWJ, MATRANGA AM et al.: Adult growth hormone deficient patients demonstrate heterogenity between childhood onset and adult onset before and during human GH treatment. J. Clin. Endocrinol. Metab. (1997) 82:82-88.
   PubMed Web of Science ®Google Scholar
• KHAN AA, HANLEY DA, BILEZIKIAN JP et al.: Standards for performing DXA in individuals with secondary causes of osteoporosis. J. Clin. Densitom. (2006) 9:47-57.
   PubMed Web of Science ®Google Scholar
• HOLMES SJ, SHALET SM: Factors influencing the desire for long-term growth hormone replacement in adults. Clin. Endocrinol. (Oxf.)(1995) 43:151-157.
   PubMed Web of Science ®Google Scholar
• CUNEO RC, JUDD S, WALLACE JD et al.: The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J. Clin. Endocrinol. Metab. (1998) 83:107-116 .
   PubMed Web of Science ®Google Scholar
• BENGTSSON BA, ABS R, BENNMARKER H et al.: The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board. J. Clin. Endocrinol. Metab. (1999) 84:3929-3935.
   PubMed Web of Science ®Google Scholar
• MUKHERJEE S, TOLHURST-CLEAVER WDJ, SMETHURST E, SHALET M: The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy J. Clin. Endocrinol. Metab. (2005) 90:1542-1549
   PubMed Web of Science ®Google Scholar
• ROSILIO M, BLUM WF, EDWARDS DJ et al.: Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H) J. Clin. Endocrinol. Metab. (2004) 89:1684-1693.
   PubMed Web of Science ®Google Scholar
• BLUM WF, SHAVRIKOVA EP, EDWARDS DJ et al.: Decreased quality of life in adult patients with growth hormone deficiency compared with general populations using the new, validated, self-weighted questionnaire, questions on life satisfaction hypopituitarism module J. Clin. Endocrinol. Metab. (2003) 88:4158-4167.
   PubMed Web of Science ®Google Scholar
• VERHELST J, ABS R, VANDEWEGHE , et al.: Two years with replacement therapy in adults with growth hormone deficiency Clin. Endocrinol. (1997) 47:485-494.
   PubMed Web of Science ®Google Scholar
• RADCLIFFE DJ, PLISKIN JS, SILVERS JB, CUTTLER L: Growth hormone therapy and quality of life in adults and children. Pharmacoeconomics (2004) 22:499-524.
   PubMed Web of Science ®Google Scholar
• HERNBERG-STAHL E., LUGER A, ABS R et al.: Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. J. Clin. Endocrinol. Metab. (2001) 86:5277-5281.
   PubMed Web of Science ®Google Scholar
• CLAYTON PE, CUNEO RC, JUUL A, MONSON JP, SHALET SM, TAUBER M: Consensus statement on the management of the GH-treated adolescent in the transition to adult care Eur. J. Endocrinol. (2005) 152:165-170.
   PubMed Web of Science ®Google Scholar
• SHALET SM, TOOGOOD A, RAHIM A, BRENNAN BMD: The diagnosis of growth hormone deficiency in children and adults Endocr. Rev. (1998) 19:203-223.
   PubMed Web of Science ®Google Scholar
• SHALET SM, SHAVRIKOVA E, CROMER M: Effect of growth hormone (GH) treatment on bone in postpubertal GH-Deficient Patients: a 2-year randomized, controlled, dose-ranging study J. Clin. Endocrinol. Metab. (2003) 88:4124-4129.
   PubMed Web of Science ®Google Scholar
• MAURAS N, PESCOVITZ OH, ALLADA V, MESSIG M, WAJNRAJCH MP, LIPPE B, ON BEHALF OF THE TRANSITION STUDY GROUP 2005: Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial J. Clin. Endocrinol. Metab. (2005) 90:3946-3955
   PubMed Web of Science ®Google Scholar
• TAUBER M, JOURET B, CARTAULT A et al.: Adolescents with partial growth hormone (GH) deficiency develop alterations of body composition after GH discontinuation and require follow-up. J. Clin. Endocrinol. Metab. (2003) 88:5101-5106.
   PubMed Web of Science ®Google Scholar
• SAVAGE MO, DRAKE WM, CARROLL PV, MONSON JP: Transitional care of GH deficiency: when to stop GH therapy. Eur. J. Endocrinol. (2004) 151:S61-S65
   PubMed Web of Science ®Google Scholar
• MAGHNIE M, AIMARETTI G, BELLONE S et al.: Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. Eur. J. Endocrinol. (2005) 152:589-596
   PubMed Web of Science ®Google Scholar
• ATTANASIO AF, ELENA P. SHAVRIKOVA EF, BLUM WF, SHALET SF: Quality of life in childhood onset growth hormone-deficient patients in the transition phase from childhood to adulthood J. Clin. Endocrinol. Metab. (2005) 90:4525-4529.
   PubMed Web of Science ®Google Scholar
• COLAO AM, DI SOMMA C, SPIEZIA T et al.: The natural history of partial Growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis J. Clin. Endocrinol. Metab. (2006) 91:2191-2200
   PubMed Web of Science ®Google Scholar